FDAnews Drug Daily Bulletin

ICONIX STUDY DRIVES METHODS FOR DISCOVERING AND VALIDATING PREDICTIVE TOXICOLOGY BIOMARKERS

June 26, 2006
A A

Iconix Pharmaceuticals, Inc. today announced that a study by Iconix scientists on the use of genomic data to find biomarkers to predict adverse effects of drug candidates has received the "Best Paper of 2005" award from the well known industry journal Toxicologic Pathology. Yahoo News (http://biz.yahoo.com/prnews/060623/sff017.html?.v=62)